is a transport protein of the inner mitochondrial membrane and presumably is implicated in the maintenance or tolerance of high lipid oxidation rates. Ucp3 is predominantly expressed in skeletal muscle and brown adipose tissue and is regulated by a transcription factor complex involving peroxisome proliferator-activated receptor-␣, MyoD, and COUP transcription factor II. By analysis of a mutant Djungarian hamster model lacking Ucp3 transcription specifically in brown adipose tissue, we identified a putative transcription factor-binding site that confers tissue specificity. A naturally occurring intronic point mutation disrupting this site leads to brown adipose tissue-specific loss of Ucp3 expression and an altered body weight trajectory. Our findings provide insight into tissue-specific Ucp3 regulation and, for the first time, unambiguously demonstrate that changes in Ucp3 expression can interfere with body weight regulation.
uncoupling protein 3; intronic binding site UNCOUPLING PROTEIN (Ucp)3 belongs to the group of anion carrier proteins and is located within the inner mitochondrial membrane. It is predominantly expressed in skeletal muscle and brown adipose tissue (BAT) (1, 31) . Initially described as a homolog of classical brown fat thermogenic Ucp1, it was soon established that Ucp3 has a function other than thermogenesis. One major argument against a thermogenic role was the positive transcriptional regulation of the Ucp3 gene in response to starvation in which activation of an energy-wasting mechanism seems unlikely (13) . Many studies have described Ucp3 upregulation in response to further physiological situations associated with increased plasma fatty acid levels and lipid utilization including cold exposure (32) , acute exercise (8) , and streptozocin-induced diabetes (25) as well as direct lipid infusion (35) . The inferred relevance of this anion carrier protein in lipid metabolism is the cornerstone of the hypothesis of Ucp3 being a fatty acid anion exporter, a biochemical function necessary to eliminate free fatty acids from the mitochondrial matrix and not assigned to a specific protein previously (20) . This molecular function of Ucp3, however, is subject to an ongoing debate (16) . Despite its obviously different role in vivo, certain biochemical properties of the protein as measured in mitochondrial proton leak assays resemble those of Ucp1, i.e., causing a GDP-sensitive inducible proton leak (27) . Therefore, other major hypotheses consider Ucp3 to primarily be a proton translocator, pyruvate transporter, superoxide transporter, constituent of a radical defense system, and constituent of the mitochondrial Ca 2ϩ uniporter (for reviews, see Refs. 16 and 28) .
Apart from the controversy about the actual molecular function, there is general consent that Ucp3 is implicated in the maintenance or tolerance of high lipid oxidation rates by either being an integral part of fatty acid metabolism or an accompanying phenomenon. In addition to its localization in tissues with high ␤-oxidative capacities and its regulation by serum free fatty acid levels, there is complementary evidence for a role in lipid metabolism from a different perspective. In a number of association and linkage studies, polymorphisms in the human UCP3 locus have been reported to influence markers of obesity like the body mass index and waist-to-hip ratio (2, 17) . Since Ucp3 and Ucp2 share the same genomic locus and are well within linkage disequilibrium, it has been problematic to assign association of the respective phenotype to a polymorphism in either of the paralogs (2, 33) .
In our breeding colony of Djungarian hamsters (Phodopus sungorus), we identified animals lacking Ucp3 mRNA expression exclusively in BAT without phenotypic consequences for the resting metabolic rate (11) . When challenged by cold exposure, these animals display defective BAT function and decreased cold tolerance limit accompanied by a global downregulation of metabolic BAT gene expression (15) . We further analyzed this mutation on a broad genetic background to elucidate the affected regulatory mechanism and the phenotypic consequences.
The expression of Ucp3 is controlled by an interacting network of multiple factors including peroxisome proliferatoractivated receptor (PPAR)-␣/retinoid X receptor (RXR)-␣ heterodimers, MyoD, COUP-transcription factor II (COUP-TFII), and several more (7, 23) . The function of all these known components of the machinery controlling Ucp3 transcription is mediated by the genomic region upstream of Ucp3 exon 1. Here, we report on a novel regulatory element in intron 1 that is essential for brown fat Ucp3 transcription and thereby confers tissue specificity of Ucp3 expression. We show that disruption of this element leads to BAT-specific loss of Ucp3 expression and an altered body mass trajectory.
EXPERIMENTAL PROCEDURES
DNA sequence analysis. We chose primers for comparative sequencing of the hamster Ucp3 locus with Primer3 software (see Ref. 19 ) based on GenBank entry AY523564 to yield overlapping PCR fragments of ϳ500 bp in length. Amplicons were Sanger sequenced from both ends. Sequences were aligned and analyzed with the GAP module of the Staden package (24) . Sequence positions and variations are named following nomenclature recommendations and were based on GenBank entry AY523564 (4). Accordingly, positions in intron 1 are called intervening sequence 1 (IVS1)ϩx, counting from the first base (ϩ1) of this intron. Positions outside introns are given relative to the A (ϩ1) of start codon ATG in AY523564. Analyses of transcription factor-binding sites were conducted with MATCH and PATCH (both Biobase) and MatInspector (Genomatix). Information about transcription factor-binding sites was extracted from MatBase Matrix Library 8.0 (Genomatix).
For two sequence variations located in Ucp3 intron 1, we developed restriction fragment length polymorphism (RFLP) assays. The region surrounding IVS1ϩ1505A constitutes a recognition site for AarI that is absent when the IVS1ϩ1505G allele is present. At IVS1ϩ2668A, there is an Eco57I site that is lacking if the IVS1ϩ2668G allele is present. We amplified a genomic fragment including both polymorphic sites with primers 5Ј-TGTCCTGATGGCTCCTCTCTA-3Ј/5Ј-CCCCAGGAACT-TCACAACTG-3Ј and digested fragments with either AarI (Fermentas) or Eco57I (Fermentas).
To genotype a larger number of animals, we used the Pyrosequencing technique with the PSQ 96MA system (Biotage AB). We first amplified a long intronic DNA fragment with primers 5Ј-CAAG-TCACCCAGCAGCCTA-3Ј/5Ј-GGCGGCATCTATCTGGAATA-3Ј. In a second nested PCR, we used primers 5-ЈCAGTACCTCCTGCT-GGGAAG-3Ј and 5Ј-biotinylated Biotin-AGTCAGACCTTGGCTC-TCCA-3Ј to amplify a 248-bp-long region encompassing IVS1ϩ1505. The total yield of biotin-labeled PCR product was immobilized on 3-l steptavidin-labeled Sepharose beads (GE Healthcare) at room temperature. Single-stranded DNA was prepared at a Vacuum Work Station (Biotage) and transferred into a PSQ reaction plate (Biotage), where the sequencing primer 5Ј-GCCTGAATAAGTGTTTTCT-3Ј was annealed. Pyrosequencing reactions were performed using the PyroGold SNP reaction kit (Biotage) following the manufacturer's instructions. The sequence to analyze was defined as 5Ј-TAACACRCCTG-3Ј and the dispensation order for the single nucleotide injection was calculated to be 5Ј-GTACACGAGC-3Ј (where bold letters indicate the polymorphic site) by PSQ 98MA software (version 2.1, Biotage). Results were calculated and analyzed by PSQ 98MA software.
Animal growth, body mass, and composition. We genotyped position IVS1ϩ1505 of animals randomly chosen from our colony. To study the phenotypic consequences of the two alleles of Ucp3 intron 1 in vivo, on a broad genetic background and in all genotypes, we crossed heterozygous hamsters. The progeny of 14 heterozygous breeding pairs displayed an allele frequency of 0.5 for IVS1ϩ1505G and 0.5 for IVS1ϩ1505A in 171 animals, as expected. The genotypes were in Hardy-Weinberg equilibrium. Body weights of all animals were continuously monitored on a weekly basis. On day 81 Ϯ 3 after birth, 66 randomly selected hamsters were transferred to an ambient temperature of 4°C to pronounce differences that may arise from altered BAT physiology. They were killed after 2 days of cold exposure.
All determinations of body fat mass and femur length were performed under isoflurane anesthesia with dual-energy X-ray absorptiometry (DEXA; PIXImus2 scanner, software version 1.46.007, GE Medical Systems). The head of the animal was excluded from measurements. Bone mass is not included in DEXA-provided values for total body mass (head excluded) and lean mass.
Animal experiments were conducted in accordance with German animal welfare law.
Quantitative PCR. We extracted total RNA from BAT and skeletal muscle with TRIzol (Invitrogen), and RNA was photometrically quantified. RNA was reverse transcribed with the Superscript III First Strand Synthesis Kit (Invitrogen). To quantify transcript levels by quantitative PCR, we used ImmoMix (Bioline) supplemented with SYBR green (Bioline) and 20 nM fluorescein (Bio-Rad) on an iCycler (Bio-Rad). The efficiency of amplification was calculated based on dilution series standard curves by Bio-Rad iCycler IQ 3.0 software and used to determine starting quantity levels (PCR baseline subtracted) normalized to ␤-actin levels. Primers were as follows: ␤-actin, 5Ј-AGAGGGAAATCGTGCGTGAC-3Ј and 5Ј-CAATAGTGATGACCT-GGCCGT-3Ј; and Ucp3, 5Ј-AGGAAGGAATCAGGGGCTTA-3Ј and 5Ј-TCCAGCAGCTTCTCCTTGAT-3Ј. Results were statistically analyzed by t-tests (SigmaStat 3.1, Systat Software).
Vector construction. Using the genomic DNA of animals either homozygous for (IVS1ϩ1505G, IVS1ϩ2668A) or (IVS1ϩ1505A, IVS1ϩ2668G), we PCR amplified fragments of 4,338 bp spanning position Ϫ4234 to ϩ103 of the Ucp3 genomic locus with primers 5Ј-CCTTGGGAAGTCAATGTCCT-3Ј/5Ј-CCAGGGGGAAGGTGAG-TAGGTCT-3Ј and Pfu polymerase (Fermentas). The amplicon included a part of the promoter, exon 1, intron 1, and most of exon 2, including the start codon. Amplicons were used in a nested Pfu-PCR to amplify the region between positions Ϫ4027 to ϩ14 with primers 5-ЈGGGG-GAAGGGAAACGGGGAGAC-3Ј/5Ј-GAAGTCCAACCATGGTGC-CCAGCAG-3Ј, the latter of which is heterologous in one base position (underlined), creating a NcoI recognition site around the endogenous start codon of the Ucp3 gene. Respective amplicons were digested with BglII and NcoI, and the resulting fragment spanning the region between Ϫ3555 to ϩ3 was gel purified and cloned into the respective restriction sites of pGL3-basic (Promega). By sequencing, we identified clones without PCR-introduced errors representing the two alleles (IVS1ϩ1505G, IVS1ϩ2668A) and (IVS1ϩ1505A, IVS1ϩ2668G) (corresponding to vectors 1 and 2 in Fig. 2A ).
We next generated constructs representing the two alleles not present in our colony, (IVS1ϩ1505A, IVS1ϩ2668A) and (IVS1ϩ1505G, IVS1ϩ2668G) (corresponding to vectors 3 and 4 in Fig. 2A ). To do so, we cut vectors 1 and 2 into two fragments each with KpnI (Fermentas), with both fragments either containing IVS1ϩ1505 or IVS1ϩ2668. These fragments were gel purified and ligated crosswise, yielding vectors 3 and 4.
Reporter gene assays. We conducted reporter gene assays in the hibernoma-derived mouse brown adipocyte cell line HIB1B and the mouse myoblast cell line C2C12 established from normal leg muscle. HIB1B cells were grown in DMEM-F-12 (Gibco) containing 10% FCS (Biochrom) until confluence. To differentiate the cells, we decreased the FCS content to 7% and added 17 nM insulin (Sigma) for ϳ10 days. C2C12 cells were grown in DMEM containing 10% FCS until confluence and then switched to DMEM with 2% horse serum to induce differentiation.
Both cell lines were transfected by the nucleofection method (Amaxa) according to the manufacturer's recommendations for the respective cell line. After nucleofection, cells were incubated for an additional 24 h with fresh medium. Rosiglitazone (20 M, PPAR-␥ agonist) dissolved in ethanol and Wy14,643 (10 M, PPAR-␣ agonist) in DMSO were added during this medium change where stated. These compounds have previously been shown to increase Ucp3 expression (12, 14) . In all measurements without stimulant, medium was supplied with a comparable volume of DMSO and ethanol only. Photinus luciferase activity was measured with components of the Dual Luciferase Reporter Assay System (Promega). We deliberately refrained from usage of a Renilla luciferase reference construct as explained previously (7) . All measurements were replicated at least three times independently including nucleofection.
EMSA. Besides HIB1B and C2C12 cells, we also used an immortalized BAT cell line in EMSA that was kindly provided by B. Spiegelman (29) . All cell lines were grown on a 10-cm culture plate and harvested after full differentiation and either 24 h of stimulation with 20 M
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Physiol Genomics • VOL 38 • www.physiolgenomics.org on January 29, 2010 physiolgenomics.physiology.org rosiglitazone and 10 M Wy14,643 or left untreated. Nuclear protein was isolated, and complementary oligonucleotides were annealed as previously described (7) . To prepare nuclear extracts from C2C12 cells, we used a different published protocol (21) . Sequences of the double-stranded oligonucleotide probes (sense strand) were as follows: IVS1ϩ1505G, 5Ј-GTGTTTTCTTAACACGCCTGCACTGTTGGTA-3Ј; IVS1ϩ1505A, 5Ј-GTGTTTTCTTAACACACCTGCACTGTTGGTA-3Ј; NF-B binding, 5Ј-TTGGCTGTGGTACTTTCCAACGGAA-3Ј, and MyoD binding, 5Ј-CCCCCAACAGCTGTTGCCTGA-3Ј. The sense strand of each probe carried a 5Ј-Cy5 modification for nonradioactive detection. For gel retardation assays, we incubated 3-5 g of nuclear extract with ϳ50 fmol of probe for 20 min on ice in a final volume of 10 l containing 4% (vol/vol) glycerol, 1 mM MgCl 2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM Tris⅐HCl (pH 7.5), and 50 g/ml poly(dIdC)⅐poly(dIdC). Samples were analyzed by electrophoresis with a 5.2% nondenaturing polyacrylamide gel at 4°C and 200 V for 3 h in 0.5ϫ TBE. The gel was documented using a Typhoon TRIOϩ imaging station (GE Healthcare).
Western blot analysis. Total protein was prepared from skeletal muscle and BAT of control hamsters, and protein concentrations were determined using the Bradford method. Protein (30 g) was loaded by SDS-PAGE and transferred to a nitrocellulose membrane (Hybond-C extra, Amersham Biosciences) in a semidry electroblotting chamber. Successful protein transfer was controlled by Ponceau staining of the membrane. Ucp3 protein was detected using a rabbit Ucp3 antibody (kindly provided by R. Porter), which was, in turn, bound by a goat anti-rabbit horseradish peroxidase-conjugated IgG secondary antibody (Dako) and developed by a chemiluminescence reagent (Supersignal, Pierce).
Statistical analysis. We statistically analyzed the body weight development of hamsters with different genotypes. Raw body mass data were included into two-way repeated-measures ANOVA with "sex" (male or female) and "genotype" (IVS1ϩ1505: AA, GA, or GG) as factors for between-group comparisons and "age" as withingroup comparison factors (33 measurements, Statistika '99 Edt., StatSoft). All complete individual data sets were included and were collected between weeks 4 and 36 of age.
mRNA expression levels of the Ucp3 gene as measured by quantitative PCR were tested for group differences with the Mann-Whitney rank sum test (SigmaStat 3.1, Systat Software).
RESULTS
The hamster Ucp3 gene exhibits two alleles. To detect sequence variations associated with the lack of Ucp3 expression in BAT, we sequenced 12,721 bp of the P. sungorus Ucp3 gene including all seven exons, all introns, and 3,632 bp of the promoter region. We compared sequences derived from two wild-type hamsters with two Ucp3-deficient ("mutant") hamsters. Sequences were identical except for two positions within the first intron (Fig. 1A) . At position IVS1ϩ1505, both wild-type hamsters were heterozygous G/A, whereas both mutant animals were homozygous for allele A. At position IVS1ϩ2668, wildtype hamsters were heterozygous G/A, whereas mutant animals were homozygous for allele G (Fig. 1A) .
We developed RFLP assays for both sequence variations IVS1ϩ1505GϾA and IVS1ϩ2668AϾG and genotyped 43 hamsters of our breeding colony. The genotype distribution indicated the presence of two haplotypes: (IVS1ϩ1505G, IVS1ϩ2668A) and (IVS1ϩ1505A, IVS1ϩ2668G).
A single base exchange is responsible for the expression phenotype. To elucidate whether these two polymorphic sites are responsible for the expression phenotype, we constructed four different reporter gene vectors harboring a minimal Ucp3 promoter, the first exon, the complete first intron, and the untranslated region of the second exon. The endogenous ATG was used as the start codon for the luciferase open reading frame. The four vectors differed in haplotypes of the two intron 1 polymorphic sites, as shown in Fig. 2A, i .e., vector 1 (IVS1ϩ1505G, IVS1ϩ2668A; GA), vector 2 (IVS1ϩ1505A, IVS1ϩ2668G; AG), vector 3 (IVS1ϩ1505A, IVS1ϩ2668A; AA), and vector 4 (IVS1ϩ1505G, IVS1ϩ2668G; GG).
Nucleofection of these vectors into differentiated HIB1B brown adipocytes revealed allele-specific reporter gene expression (Fig. 2B) . The basal activity of vector 1 (GA) and vector 4 (GG) was 10-fold higher than of vector 2 (AG) and vector 3 (AA). Induction by PPAR agonists led to a strong increase of expression in vector 1 (GA) and vector 4 (GG) but not in vector 2 (AG) and vector 3 (AA). In this condition, the two vectors exhibiting IVS1ϩ1505G displayed an ϳ100-fold higher reporter gene activity than vectors with IVS1ϩ1505A. Thus, both basal activity and induction by PPAR agonists were dependent on the presence of allele G at position IVS1ϩ1505.
In differentiated C2C12 myotubes, we did not observe differences in basal expression levels of the four vectors. Upon stimulation with PPAR agonists, however, the expression of vectors 1 and 4 with IVS1ϩ1505G was slightly upregulated, whereas vectors 2 and 3 with IVS1ϩ1505A retained their basal levels (Fig. 2B) .
Ucp3 expression is silenced by allele IVS1ϩ1505A in vivo. We analyzed Ucp3 expression of 2-day cold-exposed hamsters at the age of 83 Ϯ 3 days with respect to genotypes at positions IVS1ϩ1505 and IVS1ϩ2668. As the polymorphisms are coupled (see above), we give results for functional IVS1ϩ1505 only. In BAT, Ucp3 mRNA expression showed marked differences based on the genotype (Fig. 3A) . Heterozygous animals had a 30% lower mRNA abundance than homozygous IVS1ϩ1505G animals, whereas homozygous IVS1ϩ1505A hamsters were virtually devoid of Ucp3 mRNA. In skeletal muscle tissue, Ucp3 mRNA expression was lowest in homozygous IVS1ϩ1505A animals and significantly higher in homozygous IVS1ϩ1505G animals with an intermediary Ucp3 mRNA level in heterozygous hamsters. The Ucp3 protein level was determined later and, thus, in hamsters of considerably greater age that we did not expose to cold. Nevertheless, the differences in protein levels very well reflected the mRNA data. There were clear genotype-and tissue-specific differences in expression (Fig. 3B) .
The mutant allele is naturally occurring. To determine allele frequencies in our hamster colony, we cumulated RFLP results from the 43 animals initially genotyped and of 90 animals genotyped to establish heterozygous breeding pairs. By pyrosequencing, we genotyped an additional 97 animals randomly chosen from our breeding colony totalling 230 hamsters. Of these, 105 hamsters were homozygous IVS1ϩ1505G, 104 hamsters were heterozygous, and 21 hamsters were homozygous IVS1ϩ1505A, resulting in an allele frequency of 0.68 for IVS1ϩ1505G and 0.32 for IVS1ϩ1505A (Fig. 4A) . The observed genotypes were in Hardy-Weinberg equilibrium.
To further evaluate the distribution of IVS1ϩ1505A, we collected samples from five different breeding colonies of P. sungorus in the United States, Canada, and Europe (Fig. 4A) . Two of those had been established independently from the Marburg colony. Most Djungarian hamsters in research laboratories nowadays can be traced back to the K. Hoffmann and J. Figala colony at the Max Planck institute in Andechs, Germany (26) . This is true for our animals (allele frequency for IVS1ϩ1505A ϭ 0.37) as well as for the commercial supplier, Wrights (Essex, UK), where J. Mercer (0.97) and A. Loudon (1.00) obtained their founder animals (personal communications and Ref. 5). S. Steinlechner (0.03) and C. Wynne-Edwards (0.23) trapped wild animals in Siberia and established independent colonies in their laboratories that have never been interbred with animals of a different origin (personal communications and Ref. 36 ). In samples of hamsters from both colonies, we identified the mutant allele. Since in S. Steinlechner's samples we only found a single heterozygous animal, we confirmed our results by genotyping the offspring of this animal and could again identify IVS1ϩ1505A.
T. Bartness' hamsters (IVS1ϩ1505A ϭ 0.07) originate from the Hoffmann-Figala line and were interbred with animals from S. Steinlechner and C. Wynne-Edwards (personal communications).
We confirmed a strongly decreased Ucp3 transcript abdundance in BAT of mutant hamsters from J. Mercer and A. Loudon compared with heterozygous and wild-type hamsters from C. Wynne-Edwards (Fig. 4B) . (vectors 1-4) . All four possible haplotypic combinations were tested. B: luciferase activity is shown relative to the activity of the unstimulated construct (vector 1) representing the wild-type allele. Errors are standard deviations. In HIB1B cells, both constructs containing IVS1ϩ1505G showed 10-fold higher basal activity than constructs harboring IVS1ϩ1505A, whereas position IVS1ϩ2668 did not seem to play a role. When cells were stimulated with peroxisome proliferator-activated receptor (PPAR) agonists, this difference increased to 100-fold. In C2C12 cells, the basal activity of all constructs was comparable. When stimulated, IVS1ϩ1505G constructs increased activity by ϳ50%, whereas IVS1ϩ1505A constructs did not change expression. Taken together, the allele IVS1ϩ1505A was found in every colony analyzed including all independently established ones.
Differential complex formation in EMSA. One potential link between a sequence variation and a defective transcriptional regulation is the loss or impairment of a transcription factorbinding site. To investigate this possibility, we performed EMSAs with probes representing the polymorphic intronic site IVS1ϩ1505 and nuclear extracts isolated from several cell lines stimulated with Wy14,643 and rosiglitazone (Fig. 5) . In HIB1B cells, this treatment has been proven to induce the allele-specific expression phenotype in our reporter gene assays.
Stimulated HIB1B nuclear extracts led to the formation of several protein-DNA complexes on the IVS1ϩ1505G probe that were distinctly weaker on the IVS1ϩ1505A probe (Fig.  5A) . The same pattern was observed with extracts from a different immortalized BAT cell line (29) . No complex formation on either probe was observed using extracts of stimulated C2C12 myotubes. All three nuclear extracts formed complexes on positive control probes representing published binding ele- Fig. 4 . Both alleles are present in the wild population. A: allele frequencies of IVS1ϩ1505G (shaded) and IVS1ϩ1505A (solid) in six international colonies proved the occurrence of both alleles in the natural habitat. The colonies of Klingenspor, Steinlechner, and Wynne-Edwards are completely independent and have never been interbred. Hamsters from the Mercer and Loudon colonies can be traced back to the same source as our (Klingenspor) hamsters. The Bartness animals are a product of interbreeding hamsters from all these lines. B: hamsters of three different colonies were phenotyped (n ϭ 3 each). Mutant hamsters from J. Mercer and A. Loudon displayed strongly decreased Ucp3 mRNA abundance compared with wild-type (n ϭ 1) and heterozygous (n ϭ 2) hamsters from C. Wynne-Edwards. a.u., Arbitrary units. ments for transcription factors NF-B and MyoD, respectively (10, 34) .
Notably, the stimulation of HIB1B cells with Wy14,643 and rosiglitazone did not change the pattern of complexes formed by nuclear protein with either probe (Fig. 5B) .
We investigated the specificity of this differential complex formation in EMSA with competing probes (Fig. 5C ). Unlabeled IVS1ϩ1505G probe itself was able to efficiently disrupt complex formation of HIB1B nuclear protein with its labeled counterpart. Unlabeled IVS1ϩ1505A probe displayed a markedly lower competition potential. The probe for NF-B was used as a negative control and did not compete for this complex at all.
Analysis of putative transcription factor-binding sites. The sequence element surrounding IVS1ϩ1505 was identified in the first intron of the Ucp3 gene in all analyzed vertebrates (Fig. 6A) . Among these vertebrates, the G nucleotide at position IVS1ϩ1505 is conserved. We derived a consensus sequence from this alignment and analyzed it for potential transcription factor-binding sites (see Supplemental Material). All three algorithms recognized a binding site for proteins of the forkhead factor family.
To verify binding of one of the more than 40 members of this family, we designed competitor oligonucleotides representing forkhead factor-binding sites. We extracted all 15 known binding matrixes from the MatBase database (Genomatix) and grouped them by similarity (Supplemental Material). 1 We were able to design 5 sequences (sequences A-E) to represent the 15 ambiguous matrixes. The predicted forkhead factor-binding site on our wild-type hamster probe was replaced by one of these five elements (A-E) and tried to compete with the protein-DNA interaction on the hamster wild-type probe in bandshift assays. Whereas unlabeled wildtype probe was clearly able to compete stronger than the unlabeled mutant probe in a control experiment, none of the five unlabeled forkehead factor-binding probes was able to compete stronger than the negative control (Supplemental Material).
The G allele at position IVS1ϩ1505 led to altered body weight development. We kept offspring of heterozygous breeding pairs at room temperature under long-day conditions (16: 8-h light-dark cycle) with ad libitum access to food and water and monitored body weights. At the age of 81 Ϯ 3 days, 66 hamsters were transferred to 4°C ambient temperature to pronounce any differences that may arise from altered BAT physiology. After 2 days of cold exposure, hamsters were killed and organ weights were determined. We weighed suprasternal BAT, interscapular BAT, inguinal white adipose tissue, and the spleen. None of these displayed significant differences with respect to genotype at IVS1ϩ1505. The same was true for the difference in body mass before and after cold exposure (Supplemental Material).
We did, however, find a differential development of body weight (Fig. 7) . Both male and female animals that were homozygous for IVS1ϩ1505G displayed a lower body mass than carriers of IVS1ϩ1505A. Heterozygous hamsters tended to increase body weight in a similar fashion as hamsters homozygous IVS1ϩ1505A. This pattern of genotypespecific body weight trajectory was very similar in male and female hamsters. The development of body weight over time was significantly influenced by the genotype of the animals ( Table 1) .
To allocate this difference, we measured the body composition of 108 hamsters aged 259 -289 days by DEXA, but we did not detect any significant genotype effects on body composition. As a measure for body size, we determined the lengths of the femur of all animals from these X-ray pictures and did not find a significant genotype effect on size (Supplemental Material). The significant difference in body mass trajectory was neither clearly attributable to fat or lean mass nor to an overall increase in body size.
DISCUSSION
In our breeding colony of the Djungarian hamster (P. sungorus), we identified animals exhibiting a heritable BATspecific lack of Ucp3 mRNA (11). We were able to pinpoint the underlying genetic variation by resequencing of the Ucp3 gene in several animals. Surprisingly, it turned out to be a single-nucleotide variation located in the first intron (IVS1ϩ1505), i.e., far away from all regulatory elements known so far, which are found in the proximal promoter region and further upstream (7, 22, 23) . Differential complex formation around IVS1ϩ1505 in EMSA and in silico analyses implied a function as a binding site for a transcriptional regulator.
In reporter gene assays as well as in vivo, allele IVS1ϩ1505A led to complete loss of expression in BAT only, wheras in skeletal muscle cells only a mild phenotype was observed. Stimulation with PPAR-␣/␥ ligands led to a lesspronounced activation of the Ucp3 promotor in C2C12 cells, probably due to a different pattern of expressed PPAR isoforms. The comparison of promoter construct activity in the absence of agonists, however, revealed that the difference between IVS1ϩ1505G and IVS1ϩ1505A was less pronounced in C2C12 cells. In EMSA experiments, nuclear extracts of two brown adipocyte cell lines led to allele-specific complex formation, whereas in myotubes the binding factor was obviously absent. We conclude that the affected element very probably is a regulator of tissue-specific Ucp3 expression. So far, the molecular basis of this tissue specificity is unknown, and differences in the activity of known transcription factors like PPAR-␣ and -␦ have been implicated (18, 22) . Interestingly, treatment of HIB1B cells with agonists for PPAR-␣/␥ led to increased wild-type promoter activity in reporter gene assays but not to increased complex formation in EMSA. Therefore, these PPARs and their direct targets do not seem to be constituents of the regulatory complex binding around IVS1ϩ1505. Formation of a protein complex on this intronic element appears rather to be a switch allowing PPAR-dependent promoter transactivation, which itself is mediated by the proximal promoter (23) .
This distinct intronic regulatory element is responsible and essential for the BAT-specific expression of Ucp3. Analysis of the conserved consensus sequence based on the sequence comparison of several vertebrate species revealed a putative transcription factor-binding site that includes a conserved G nucleotide at hamster position IVS1ϩ1505. Several programs consistently predicted a binding site for forkhead domain transcription factors among other possible candidates. However, competition experiments did not yield any supportive evidence for binding of a forkhead factor, although all known 15 binding matrixes were tested. Our group is currently establishing affinity chromatography and yeast one hybrid assays to identify the interacting protein.
The presence of Ucp3 in both skeletal muscle and brown adipose tissue has been reported for all species analyzed in this respect so far including mice (31) and rats (1) . Since hamsters carrying the IVS1ϩ1505G allele display this known distribution of Ucp3 and all analyzed sequences exhibit a G nucleotide at the orthologous intron position, we consider IVS1ϩ1505G to be the ancestral allele and IVS1ϩ1505A to be the derived allele. Our screening for IVS1ϩ1505A and IVS1ϩ1505G in several international breeding colonies of P. sungorus identified IVS1ϩ1505A in all colonies including three independently founded ones. This clearly shows that the mutation generating IVS1ϩ1505A did not occur in captivity but in the wild. In fact, it indicates a rather high allele frequency in the wild population being incidentally trapped for three times at different times and places. Without any knowledge about the actual allele frequencies in the wild, however, we can merely conclude the lack of any dramatic negative consequences of IVS1ϩ1505A regarding overall fitness. In the colonies of J. Mercer and A. Loudon, homozygous IVS1ϩ1505A also led to the loss of BAT Ucp3 expression.
Beyond this study, the knowledge about the existence of IVS1ϩ1505A and its primary expression phenotype may prove valuable to further study of the function of Ucp3. So far, there are Ucp3 Ϫ/Ϫ mouse models available and transgenic mice overexpressing the protein (1, 3, 6, 9, 30 ). With the Djungarian hamster, we now have access to an animal model with a tissue-specific lack of expression that can be applied to elucidate tissue-specific protein function. Furthermore, knowledge about IVS1ϩ1505A will help researchers working with Djungarian hamsters to select animals of the appropriate genotype for their respective study.
The implication of Ucp3 in the regulation of body mass has long been disputed. There are several studies that have described an interrelation of polymorphisms within the human UCP3 gene and markers of obesity, especially Ϫ55(T/C) located in the promoter region (2, 17, 33) . The proximity of the UCP2 gene has always raised the question of whether these effects can doubtlessly be ascribed to UCP3 or possibly to additional polymorphisms within linkage disequilibrium (33) . In this study, we demonstrate that a change in Ucp3 expression can be responsible for altered body weight development. In this respect, heterozygous hamsters seemed to resemble homozygous IVS1ϩ1505A hamsters rather than homozygous IVS1ϩ1505G hamsters. This dominant body weight phenotype would imply that small changes of Ucp3 expression levels could already lead to a full-scale impact on body weight development.
The involvement of Ucp3 in energy balance is substantiated by its transcription being correlated to serum fatty acid levels and its presence in tissues with exceptional ␤-oxidative capacities (35) . The absence of a body weight phenotype in Ucp3 Ϫ/Ϫ mice (9, 30), however, questioned the relevance of Ucp3 in this context. Our demonstration of differential body weight development in response to altered Ucp3 expression reopens this discussion. In fact, it cannot be ruled out that comparable effects were simply overlooked in Ucp3 Ϫ/Ϫ mice. All published analyses of body weight development in these animal models used far fewer animals and shorter study periods than in this study and so would probably not have been sufficient to reveal an effect of this size. In contrast to Ucp3 Ϫ/Ϫ mice, however, our hamster model lacks Ucp3 specifically in BAT, whereas skeletal muscle expression is only mildly impaired. The genotype of an animal significantly influenced the development of body weight with age in both sexes.
Nevertheless, we cannot decide on the tissue that fundamentally accounts for the body weight divergence. Our group recently demonstrated that mutant hamsters display an impaired BAT function leading to reduced cold tolerance. This phenomenon is accompanied by a global decrease in BAT metabolic gene expression (15) . Such consequences of a complete lack of Ucp3 in BAT seem tempting to be held responsible, but even a small change in skeletal muscle may significantly contribute to the observed phenotype given the huge fraction of body mass and metabolism it represents. In any case, it is surely worthwhile to comparatively resequence human UCP3 intron 1 to identify possible single-nucleotide polymorphisms in this novel regulatory region.
Taken together, we identified an intronic element within the Ucp3 gene that is essential for BAT expression of this gene and constitutes a transcription factor-binding site. A naturally occurring mutation disrupting this element in the homozygous state leads to complete loss of BAT Ucp3 and altered body weight development.
